| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |